BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

WaferGen Biosystems to Present at 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference; Presentation to be Webcast


2/9/2012 9:45:17 AM

FREMONT, Calif., Feb. 9, 2012 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTCBB: WGBS), an emerging genomic analysis company, today announced that the company will deliver its corporate presentation at the 14th Annual BIO CEO & Investor Conference, February 13 and 14, 2012 at the Waldorf Astoria, New York, NY.

WaferGen's presentation will begin at 2:00 p.m. Eastern Time, Monday, February 13, 2012. The presentation will be Webcast live and may be accessed at www.wafergen.com. It will be available for 90 days.

About WaferGen and the SmartChip Real-Time PCR System

WaferGen Biosystems, Inc., an emerging genomic analysis company in the early stage of commercialization, develops products to address key unmet needs in large and growing markets in disease research and personalized medicine. The company offers the transformative SmartChip Real-Time PCR Systema next-generation Real-Time PCR system for profiling and validation of gene expression patterns (biomarkers) on a single platform. The company believes that the capability of the SmartChip platform to accurately make qualitative and quantitative genome measurements is an integral tool in enabling researchers to verify the results coming from next-generation sequencers. Once verified, this content creates a larger, longer-term opportunity for WaferGen as it significantly increases the ability of researchers to validate high value genomic targets for their ultimate use in developing new/improved drugs and diagnostic tests.

The company also offers an innovative fee-based service for gene-expression profiling using the SmartChip System. For additional information, please see http://www.wafergen.com

Contacts:
WaferGen
510-651-4450

Don Huffman, CFO
don.huffman@wafergen.com

Media: Joyce Strand
joyce.strand@wafergen.com

Investors: Jeff Ransom, ProActive
jramson@proactivecrg.com
646-863-6893

SOURCE WaferGen Biosystems, Inc.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->